Patrick Rogers will receive his PhD in Organic Chemistry on June 12, 2016.
Rogers, in 2007, the year of his graduation from Howard University’s Department of Chemistry, with a BS Degree cum laude in Chemistry, could probably imagine getting his doctorate. Next month, he will accept his PhD is in Organic Chemistry with a Designated Emphasis in Biotechnology from the University of California, Davis. Since 2014, Rogers has worked at Glaxosmithkline (GSK), a British pharmaceutical giant, in a program introduced to him by Zero Chaos, a contracting agency.
In the GSK medicinal chemistry co-op, Rogers, among other duties, applies his synthetic organic chemistry skills to try to develop potential drug molecules to prevent heart failure. He also completes multi-step synthesis of potential drug molecules.
Rogers’ PhD is in Organic Chemistry with a Designated Emphasis in Biotechnology from the University of California, Davis. Rogers is a member of the National Organization for the Professional Advancement of Black Chemists and Chemical Engineers (NOBCCHE) and has received support from the Association of United Negro College Fund Merck Fellows.
